REQUEST A DEMO
Total
USD $0.00
Search more companies

Wangphaesach Pharmaceutical Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Wangphaesach Pharmaceutical Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Wangphaesach Pharmaceutical Company Limited is an enterprise located in Thailand, with the main office in Songkhla. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on June 01, 1995. 12 (2024) employees currently work for Wangphaesach Pharmaceutical Company Limited. The company’s latest financial report indicates a net sales revenue increase of 29.13% in 2024. Its total assets grew by 25.42% over the same period. The net profit margin of Wangphaesach Pharmaceutical Company Limited decreased by 0.75% in 2024.

Headquarters
23 Soi Pattano
Songkhla; Southern Thailand; Postal Code: 90110

Contact Details: Purchase the Wangphaesach Pharmaceutical Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Wangphaesach Pharmaceutical Company Limited report to view the information.
Financial Auditors:
Purchase the Wangphaesach Pharmaceutical Company Limited report to view the information.
Incorporation Date:
June 01, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Wangphaesach Pharmaceutical Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
29.13%
Total Operating Revenue
26.31%
Operating Profit
-12.33%
EBITDA
-12.33%
Net Profit/Loss for the Period
-22.43%
Total Assets
25.42%
Total Equity
5.39%
Operating Profit Margin
-0.99%
Net Profit Margin
-0.75%
Return on Equity (ROE)
-3.93%
Debt / Equity
-8.25%
Quick Ratio
0.28%
Cash Ratio
0.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?